Holen Sie sich die Stockscreener-App
3.47
2.97%
0.10
Handel nachbörslich:
3.46
-0.01
-0.29%
Autonomix Medical Inc Aktie (AMIX) Neueste Nachrichten
Autonomix Medical Shares Rise on New Patent for Cancer Treatment - MarketWatch
What's Going On With Autonomix Medical Stock Monday? - Benzinga
Autonomix granted U.S. patent for catheter-based technology - TipRanks
Autonomix Medical, Inc. Announces U.S. Patent Granted - GlobeNewswire
Autonomix Medical Patents Breakthrough Cancer Pain Treatment with 3000x Greater Sensitivity - StockTitan
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - The Manila Times
Autonomix Medical CEO Unveils Strategic Vision in Latest Corporate Update - StockTitan
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality - The Manila Times
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial - GlobeNewswire
Autonomix Medical Strengthens FDA Strategy with Key Regulatory Hire Ahead of Clinical Trials - StockTitan
Autonomix Medical (AMIX) & The Competition Critical Survey - Defense World
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward A U.S. Pivotal Trial in 2025 - Marketscreener.com
Contrasting Autonomix Medical (AMIX) & Its Competitors - Defense World
Autonomix achieves design lock for RF Ablation Catheter - TipRanks
Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 - GlobeNewswire
Autonomix Medical's Revolutionary Pain Treatment Shows 3,000x Sensitivity in Breakthrough Testing - StockTitan
AMIXAutonomix Medical, Inc. Latest Stock News & Market Updates - StockTitan
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option - The Manila Times
Autonomix Medical, Inc. Announces Closing of $10.0 Million - GlobeNewswire
Autonomix Medical Closes $10M Public Offering with Warrants to Fund Clinical Trials | AMIX Stock News - StockTitan
Autonomix Medical stock dips after pricing $9M securities offering - MSN
Autonomix Medical (NASDAQ:AMIX) vs. Perspective Therapeutics (NYSE:CATX) Critical Review - Defense World
Autonomix Medical (AMIX) & Its Rivals Head to Head Contrast - Defense World
Autonomix Medical Prices of $9.0 Million Underwritten Public Offering - citybiz
Autonomix Medical Down 53% After Pricing of $9M Offering - MarketWatch
Crude Oil Gains Over 1%; Ross Stores Earnings Top Views - Benzinga
Stock market news: Dragonfly Energy Holdings -88.31%, Autonomix Medical -53.33% among top stock losers during mid day trading - Business Upturn
Autonomix Medical slumps after $9 mln stock offering - XM
Stock market today: Dragonfly Energy Holdings -88.07%, Autonomix Medical -52.37% among top losers in early trading - Business Upturn
Dow Jumps 300 Points; Gap Posts Upbeat Earnings - Benzinga
Autonomix to sell 1.38M units at $6.54 in underwritten public offering - TipRanks
Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering - GlobeNewswire
Autonomix Medical Prices $9M Public Offering with Warrants to Fund Clinical Trials | AMIX Stock News - StockTitan
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket - Benzinga
A.M.AUTONOMY Showcases MAP-TORCH for 3D Construction Digitalization at KINTEX - GlobeNewswire Inc.
Autonomix Medical reports net loss of USD 2.8M in 3 months - Medical Buyer
Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update - The Manila Times
Autonomix reports Q2 incurred net losses $2.8M vs $6M last year - TipRanks
Autonomix Medical Inc (AMIX) Quarterly 10-Q Report - Quartz
Autonomix Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
Autonomix reports results from first 15 patients’ data on transvascular energy - MSN
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Autonomix Medical Shares Rise After Positive Trial for Pancreatic Cancer Pain Treatment - MarketWatch
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - BioSpace
Autonomix (AMIX) Gains Investor Confidence After Encouraging Trial Results - Stocks Telegraph
Autonomix Medical, Inc. Reports New Positive Topline - GlobeNewswire
Autonomix Medical (AMIX) Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - StreetInsider.com
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses - GlobeNewswire
Autonomix participates in Virtual Investor ‘What This Means’ segment - TipRanks
AMIS Stock Surges After RF Ablation Trial Unveils Positive Results - MSN
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):